Pediatric ECMO Oxygenator with Integrated Monitoring

Information

  • Research Project
  • 10008518
  • ApplicationId
    10008518
  • Core Project Number
    R43HD102245
  • Full Project Number
    1R43HD102245-01
  • Serial Number
    102245
  • FOA Number
    PA-19-272
  • Sub Project Id
  • Project Start Date
    4/23/2020 - 4 years ago
  • Project End Date
    3/31/2021 - 3 years ago
  • Program Officer Name
    TAMBURRO, ROBERT F
  • Budget Start Date
    4/23/2020 - 4 years ago
  • Budget End Date
    3/31/2021 - 3 years ago
  • Fiscal Year
    2020
  • Support Year
    01
  • Suffix
  • Award Notice Date
    4/23/2020 - 4 years ago
Organizations

Pediatric ECMO Oxygenator with Integrated Monitoring

ABSTRACT Extracorporeal membrane oxygenation (ECMO) is becoming increasingly utilized to provide cardiopulmonary support in patients due to its versatility, immediate benefit, and relatively low cost. However, there continues to be significant morbidity and mortality related to hemostatic complications, especially in the neonatal and pediatric population. A few pediatric oxygenators are used in ECMO; however, all of these devices only have short term approval and are currently used off label in ECMO. In addition, a variety of monitors are needed in an ECMO circuit, which can add to the complexity of the work flow, as well as introducing access sites that can disrupt the blood flow path. Currently, there is no such oxygenator approved for this indication in pediatrics. The goal of this project is to develop a pediatric ECMO oxygenator with integrated sensors that is optimized for long term use in pediatric ECMO. The proposed MC3 Ped-ECMO Oxygenator (PedOxy) will be designed specifically with a flow path that minimizes clotting by avoiding areas of high shear as well as stagnant zone. In addition, a simplified monitoring system will be integrated into the disposable oxygenator that will provide real-time diagnostics, minimize blood path disruptions and simplify workflows. Phase I will include optimizing the blood flow path and integrated sensor module. The manufacturing processes for creating the unique flow path will be advanced. Feasibility will be established by evaluating performance of the PedOxy against specific criteria unique to usage in the pediatric application. Phase II funding, if granted, will be sufficient to complete verification/validation testing, transfer to manufacture, and FDA and CE mark submissions. We have assembled a synergistic team of experts, clinicians, marketers, manufacturers and engineers who are uniquely qualified to carry out the proposed work.

IC Name
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT
  • Activity
    R43
  • Administering IC
    HD
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    223362
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    865
  • Ed Inst. Type
  • Funding ICs
    NICHD:223362\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    MC3, INC.
  • Organization Department
  • Organization DUNS
    806687406
  • Organization City
    DEXTER
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    481301563
  • Organization District
    UNITED STATES